Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preemptive Mefenamic Acid for Primary Dysmenorrhea
NCT03323671Phase 3Completed
- Start
- Aug 2017
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Mefenamic acid in primary dysmenorrhea (PD). Started Aug 2017; status: completed.
02
Drugs
Mefenamic acid
03
Conditions
primary dysmenorrhea (PD)
Beyond the preview
Go deeper on NCT03323671.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03323671.